SCHEMBL2799449

SCHEMBL2799449

[CH2]C(CCC)[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2800523 0.87
SCHEMBL2802985 0.78
SCHEMBL11532788 0.76
SCHEMBL1170239 0.72 ALDH1A1 (0.42)
SCHEMBL1999570 0.72 ALDH1A1 (0.42)
SCHEMBL267634 0.70
SCHEMBL7988566 0.70
SCHEMBL16907336 0.70
SCHEMBL1151111 0.70 ALDH1A1 (0.42)
SCHEMBL2801476 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676702-B2 Methods for synthesizing amatoxin building block and amatoxins HEIDELBERG PHARMA GMBH (DE) 2017-06-13 US claimed
US-9630907-B2 2017-04-25 US claimed
EP-2872479-B1 METHODS FOR SYNTHESIZING AMATOXIN BUILDING BLOCK AND AMATOXINS HEIDELBERG PHARMA GMBH (DE) 2016-06-08 EP claimed
US-20150210628-A1 METHODS FOR SYNTHESIZING AMATOXIN BUILDING BLOCK AND AMATOXINS HEIDELBERG PHARMA GMBH (DE) 2015-07-30 US claimed
EP-2872479-A1 METHODS FOR SYNTHESIZING AMATOXIN BUILDING BLOCK AND AMATOXINS Heidelberg Pharma GmbH (DE) 2015-05-20 EP claimed
WO-2014009025-A1 METHODS FOR SYNTHESIZING AMATOXIN BUILDING BLOCK AND AMATOXINS HEIDELBERG PHARMA GMBH (DE) 2014-01-16 WO claimed
EP-2684865-A1 Methods for synthesizing amatoxin building block and amatoxins Heidelberg Pharma GmbH (DE) 2014-01-15 EP claimed
CN-1078590-C Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles CATALYTICA INC (US) 2002-01-30 CN claimed
CN-1177347-A Process for preparing 2 -oxindoles and N -hydroxy -2 -oxindoles CATALYTICA INC (US) 1998-03-25 CN claimed
US-5604294-A IMMUNOSUPRESSIVE, ANTIMICROBIAL, ANTIFUNGAL, ANTIVIRAL, ANTI-INFLAMMATORY AND ANTIPROLIFERATIVE ACTIVITY ABBOTT LABORATORIES 1997-02-18 US claimed
WO-1994021635-A1 MACROCYCLIC IMMUNOMODULATORS ABBOTT LABORATORIES (US) 1994-09-29 WO claimed
US-8404860-B2 Compound having hydantoin ring and method of producing the same TOKUYAMA CORPORATION (JP) 2013-03-26 US disclosed
US-20120289705-A1 COMPOUND HAVING HYDANTOIN RING AND METHOD OF PRODUCING THE SAME SHIIGI HIROFUMI (JP) 2012-11-15 US disclosed
US-8258313-B2 Compound having hydantoin ring and method of producing the same TOKUYAMA CORPORATION (JP) 2012-09-04 US disclosed
US-20100184993-A1 COMPOUND HAVING HYDANTOIN RING AND METHOD OF PRODUCING THE SAME TOKUYAMA CORPORATION (JP) 2010-07-22 US disclosed
US-4600793-A Process for the preparation of urethanes CATALYTICA ASSOCIATES (US) 1986-07-15 US disclosed
EP-0157828-A1 PROCESS FOR THE PREPARATION OF URETHANES. CATALYTICA ASSOCIATES (US) 1985-10-16 EP disclosed
WO-1985001285-A1 PROCESS FOR THE PREPARATION OF URETHANES CATALYTICA ASSOCIATES (US) 1985-03-28 WO disclosed
US-4476290-A Photocurable silicon compound composition TOKYO SHIBAURA DENKI KABUSHIKI KAISHA (JP) 1984-10-09 US disclosed
EP-0104590-A1 Photocurable silicon compound composition KABUSHIKI KAISHA TOSHIBA (JP) 1984-04-04 EP disclosed